The role of chemokines and adhesion molecules in the pathogenesis of rheumatoid arthritis

Drugs of Today

Volumn 37, Issue 7, 2001, Pages 477-484

  Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008803828     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2001.37.7.844190     Document Type: Article

References (27)

1. Tanaka, Y., Albelda, S.M., Morgan, K.J. et al. CD31 expressed on distinctive T-cell subsets is a preferential amplifier of ̧1 integrin-mediated adhesion. J Exp Med 1992, 176: 245-53.
2. Shimizu, Y., Newman, W., Gopal, T.V. et al. Four molecular pathways of T-cell adhesion to endothelial cells: Poles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 1991, 113: 1203-12.
3. Tanaka, Y., Adams, D.H., Hubscher, S., Hirano, H., Siebenlist, U., Shaw, S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 1993, 361: 79-82.
4. Tanaka, Y., Fujii, K., Hubscher, S. et al. Heparan sulfate proteoglycan on endothelium efficiently induces integrin-mediated T-cell adhesion by immobilizing chemokines in rheumatoid synovitis. Arthritis Rheum 1998, 41: 1365-77.
5. Tanaka, Y., Mine, S., Hanagiri, T. et al. Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells. Cancer Res 1998, 58: 4138-45.
6. Tanaka, Y., Mine, S., Figdor, C.G. et al. Constitutive chemokine production results in activation of LFA-1 on adult T-cell leukemia cells. Blood 1998, 91: 3909-19.
7. Tanaka, Y., Minami, Y., Mine, S. et al. H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T-cells. J Immunol 1999, 163: 6209-16.
8. Koyarna, Y., Tanaka, Y., Salto, K. et al. Crosslinking of intercellular adhesion molecule I (CD54) induces AP-1 activation and IL-1β transcription. J Immunol 1996, 157: 5097-103.
9. Shimizu, Y., Newman, W., Tanaka, Y., Shaw, S. Lymphocyte interactions with endothelial cells. Immunol Today 1992, 13: 106-12.
10. Tanaka, Y., Adams, D.H., Shaw, S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 1993, 14: 111-5.
11. Tanaka, Y Integrin activation by chemokines: Relevance to inflammatory adhesion cascade during T-cell migration. Histol Histopathol 2000, 15: 1169-76.
12. Tanaka, Y., Kimata, K., Adams, D.H., Eto, S. Modulation of cytokine function by heparin sulfate proteoglycans: Sophisticated models for the regulation of cellular responses to cytokines. Proc Assoc Am Phys 1998, 110: 118-25.
13. Liu, Z.-J., Tanaka, Y., Fujimoto, H. et al. A novel role for H-Ras in the regulation of VLA-4 integrin and VCAM-1 via c-Myc-dependent and -independent mechanisms. J Immunol 1999, 163: 4901-8.
14. Zapico, I., Goto, E., Rodriguez, A., Alvarez, C., Torre, J.C., Alvarez, V. CCR5 DMA-polymorphism influences the severity of rheumatoid arthritis. Genes Immuno 2000, 1: 288-9.
15. Nakatsuka, K., Tanaka, Y., Hubscher, S. et al. Rheumatoid synovial cells are stimulated by the cellular adhesion to T-cells through LFA-1/ ICAM-1. J Rheumatol 1997, 24: 458-64.
16. Fujii, K., Tanaka, Y., Hubscher, S., Salto, K., Ota, T., Eto, S. Crosslinking of CD44 on rheumatoid synovial cells upregulates VCAM-1. J Immunol 1999, 162: 2391-8.
17. Aruffo, A., Stainenkovic, I., Melnick, M., Underbill, C.B., Seed, B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990, 61 : 1303-8.
18. Fujii, K., Tanaka, Y., Hubscher, S., Saito, K., Ota, T., Eto, S. Crosslinking of CD44 on rheumatoid synovial cells augments IL-6 production. Lab Invest 1999, 79: 1439-46.
19. Firestein, G.S., Yeo, M., Zvaifler, N.J. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995, 96: 1631-8.
20. Nishioka, K., Hasunuma, T., Kato, T., Sumida, T., Kobata, T. Apoptosis in rheumatoid arthritis: A novel pathway in the regulation of synovial tissue. Arthritis Rheum 1998, 41: 1-9.
21. Tanaka, Y., Nomi, M., Fujii, K. et al. ICAM-1 distinguishes functional heterogeneity of synovial cells in patients with rheumatoid arthritis. Arthritis Rheum 2000, 43: 2513-22.
22. Kavanaugh, A.F., Schulze-Koops, H., Davis, L.S., Lipsky, P.E. Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody. Arthritis Rheum 1997, 40: 849-53.
23. Feldmann, M., Maini, R.N. Anti-TNF therapy of rheumatoid arthritis: What have we learned? Annu Rev Immunol 2001, 19: 163-96.
24. Yamamoto, Y., Gaynor, R.B. Therapeutic potential of inhibition of the NF-kappa, NF-kB pathway in the treatment of inflammation and cancer. J Clin Invest 2001, 107: 135-42.
25. Szekanecz, Z., Strieter, R.M., Kunkel, S.L., Koch, A.E. Chemokines in rheumatoid arthritis. Springer Semin Immunopathol 1998, 20: 115-32.
26. Bruhl, H., Cihak, J., Stangassinger, M., Schlondorff, D., Mack, M. Depletion of CCR5-expressing cells with bispecific antibodies and chemokine toxins: A new strategy in the treatment of chronic inflammatory disease and HIV. J Immunol 2001, 166: 2420-6.
27. Youssef, S., Maor, G., Wildbaum, G., Grabie, N., Gour-Lavie, A., Karin, N. C-C chemokine-encoding DMA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J Clin Invest 2000, 106: 361-71.